Enteric adenocarcinoma lung: A rare presentation in an Omani woman

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Qureshi, Asim ^a   Furrukh, Muhammad ^a  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYTOKERATIN 20; CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORODEOXYGLUCOSE F 18; PEMETREXED; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR CDX2; ANTINEOPLASTIC AGENT; CDX2 PROTEIN, HUMAN; GLUTAMIC ACID DERIVATIVE; GUANINE; HOMEODOMAIN PROTEIN; NUCLEAR PROTEIN; THYROID NUCLEAR FACTOR 1; TRANSCRIPTION FACTOR;

ADRENAL GLAND; ADULT; ARTICLE; BASAL GANGLION; CANCER MORPHOLOGY; CANCER PALLIATIVE THERAPY; CASE REPORT; COLORECTAL CARCINOMA; DIFFERENTIAL DIAGNOSIS; FATIGUE; FEMALE; GRANULOMA; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENTAL FINDING; LUNG ADENOCARCINOMA; LUNG NODULE; MORBID OBESITY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SPLEEN; THORACOTOMY; THROMBOCYTOPENIA; UTERUS MYOMA; WEDGE RESECTION; ADENOCARCINOMA; ANALOGS AND DERIVATIVES; COLORECTAL NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; PATHOLOGY;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUTAMATES; GUANINE; HOMEODOMAIN PROTEINS; HUMANS; KERATIN-20; KERATIN-7; LUNG NEOPLASMS; MIDDLE AGED; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 84874452834     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-007667     Document Type: Article

References (10)

1. Charloux A, Quoix E, Wolkove N, et al. The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int J Epidemiol 1997;26:14-23. (Pubitemid 27129564)
2. Suzuki T, Sobue T, Fujimoto I, et al. Association of adenocarcinoma of the lung with cigarette smoking by grade of differentiation and subtype. Cancer Res 1990;50:444-7. (Pubitemid 20041256)
3. Jagirdar J. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung. Arch Pathol Lab Med 2008;132:384-96. (Pubitemid 351328813)
4. Kerr KM. Personalized medicine in lung cancer: new challenges for pathologists. Histopathology 2011;60:531-46.
5. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC eds. Pathology and genetics of tumors of the lung, pleura, thymus and heart. 3rd edn. Lyon, France: IARC Press, 2004. World Health Organization Classification of Tumors; vol 10:37-46.
6. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011;6:244-85.
7. Cagle PT, Allen TC, Dacic S, et al. Revolution in lung cancer. New challenges for the surgical pathologist. Arch Pathol Lab Med 2011;135:110-6.
8. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and CT imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005;23:3279-87. (Pubitemid 46211352)
9. Travis WD, Garg K, Franklin WA, et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol 2006;1(9 Suppl):S13-19. (Pubitemid 47181353)
10. Gaikwad K, Gupta A, Hare S. Primary adenocarcinoma of lung: A pictorial view of recent updates. Eur J Radiol 2012;81:4146-55.